187 related articles for article (PubMed ID: 19318050)
1. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells.
Arabski M; Wasik S; Dworecki K; Kaca W
J Microbiol Methods; 2009 May; 77(2):178-83. PubMed ID: 19318050
[TBL] [Abstract][Full Text] [Related]
2. Studies of antibiotic resistance of rough and smooth Proteus mirabilis strains and influence of polymyxin E on their lipopolysaccharide composition.
Kaca W; Ujazda E
Acta Microbiol Pol; 1996; 45(2):161-8. PubMed ID: 8997693
[TBL] [Abstract][Full Text] [Related]
3. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
[TBL] [Abstract][Full Text] [Related]
4. The comparison of some biological activities of lipopolysaccharides obtained from smooth and rough Proteus mirabilis strains.
Klink M; Brzychcy M; Ziółkowski A; Swierzko A; Sułowska Z; Cedzyński M; Tchórzewski H
Acta Microbiol Pol; 1998; 47(2):141-51. PubMed ID: 9839373
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of antibiotic diffusion from agarose gel by spectrophotometry and laser interferometry methods].
Arabski M; Wasik S; Piskulak P; Góźdź N; Slezak A; Kaca W
Polim Med; 2011; 41(3):25-32. PubMed ID: 22046824
[TBL] [Abstract][Full Text] [Related]
6. The properties of chitosan complexes with smooth and rough forms of lipopolysaccharides on CHO-K1 cells.
Arabski M; Lisowska H; Lankoff A; Davydova VN; Drulis-Kawa Z; Augustyniak D; Yermak IM; Molinaro A; Kaca W
Carbohydr Polym; 2013 Sep; 97(2):284-92. PubMed ID: 23911447
[TBL] [Abstract][Full Text] [Related]
7. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
Kaca W; Radziejewska-Lebrecht J; Bhat UR
Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
[TBL] [Abstract][Full Text] [Related]
8. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharide part of Proteus mirabilis lipopolysaccharide may be responsible for the stimulation of platelet adhesion to collagen.
Zielinski T; Wachowicz B; Saluk-Juszczak J; Kaca W
Platelets; 2002 Nov; 13(7):419-24. PubMed ID: 12487790
[TBL] [Abstract][Full Text] [Related]
10. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
[TBL] [Abstract][Full Text] [Related]
11. [Synergism of colistin and sulfonamide in proteus species (author's transl)].
Kunz HH
Arzneimittelforschung; 1975 Nov; 25(11):1692-5. PubMed ID: 1106440
[TBL] [Abstract][Full Text] [Related]
12. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
13. Adhesion of thrombin-stimulated and unstimulated blood platelets to collagen in the presence of Proteus mirabilis lipopolysaccharides.
Saluk-Juszczak J; Wachowicz B; Zielinski T; Kaca W
Platelets; 2001 Dec; 12(8):470-5. PubMed ID: 11798396
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ciprofloxacin and gentamicin diffusion in Proteus mirabilis O18 biofilm by laser interferometry method.
Arabski M; Wąsik S; Zych M; Lakomiec W; Kaca W
Acta Biochim Pol; 2013; 60(4):707-11. PubMed ID: 24432321
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
[TBL] [Abstract][Full Text] [Related]
16. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis.
Arabski M; Fudala R; Koza A; Wasik S; Futoma-Koloch B; Bugla-Ploskonska G; Kaca W
Clin Biochem; 2012 Nov; 45(16-17):1374-82. PubMed ID: 22749779
[TBL] [Abstract][Full Text] [Related]
17. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
McCoy AJ; Liu H; Falla TJ; Gunn JS
Antimicrob Agents Chemother; 2001 Jul; 45(7):2030-7. PubMed ID: 11408219
[TBL] [Abstract][Full Text] [Related]
18. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane proteins of smooth and rough strains of Proteus mirabilis.
Rottem S; Markowitz O; Hasin M; Razin S
Eur J Biochem; 1979 Jun; 97(1):141-6. PubMed ID: 383481
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Proteus mirabilis virulence factors and modulation by acylated homoserine lactones.
Stankowska D; Kwinkowski M; Kaca W
J Microbiol Immunol Infect; 2008 Jun; 41(3):243-53. PubMed ID: 18629420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
